Literature DB >> 16289704

Construction of an inducible, pfkA and pfkB deficient strain of Escherichia coli for the expression and purification of phosphofructokinase from bacterial sources.

Michelle R Lovingshimer1, Deborah Siegele, Gregory D Reinhart.   

Abstract

As the key obligatory step in the glycolytic pathway, the regulation of phosphofructokinase (PFK-1) has been the focus of study of several laboratories. While standard cloning procedures have opened the door to study PFK from a vast array of sources, a good pfk knockout Escherichia coli strain has not previously been developed. Many laboratories rely on DF1020 or similar derivatives for PFK expression. Unfortunately, DF1020 grows poorly and does not have an inherent means for controlling expression of genes from plasmids. More importantly, however, DF1020 has a tendency to grow on minimal media when glucose is used as the sole carbon source. In this study, a new E. coli PFK expression strain lacking both PFK-1 and PFK-2 has been engineered using lambda-red mediated chromosomal deletion. The resulting strain has been designated RL257. In addition to having both pfkA and pfkB deleted, RL257 contains the lacI(q) allele, which allows for inducible expression when coupled with an expression vector containing either the lac or tac promoter.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16289704     DOI: 10.1016/j.pep.2005.09.015

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  13 in total

1.  A pathway closely related to the (D)-tagatose pathway of gram-negative enterobacteria identified in the gram-positive bacterium Bacillus licheniformis.

Authors:  Edwige Van der Heiden; Michaël Delmarcelle; Sarah Lebrun; Régine Freichels; Alain Brans; Christian M Vastenavond; Moreno Galleni; Bernard Joris
Journal:  Appl Environ Microbiol       Date:  2013-03-22       Impact factor: 4.792

2.  Structure of the apo form of Bacillus stearothermophilus phosphofructokinase.

Authors:  Rockann Mosser; Manchi C M Reddy; John B Bruning; James C Sacchettini; Gregory D Reinhart
Journal:  Biochemistry       Date:  2012-01-11       Impact factor: 3.162

3.  The effect of introducing small cavities on the allosteric inhibition of phosphofructokinase from Bacillus stearothermophilus.

Authors:  Amy M Whitaker; Gregory D Reinhart
Journal:  Arch Biochem Biophys       Date:  2016-07-29       Impact factor: 4.013

4.  Modification of glycolysis and its effect on the production of L-threonine in Escherichia coli.

Authors:  Xixian Xie; Yuan Liang; Hongliang Liu; Yuan Liu; Qingyang Xu; Chenglin Zhang; Ning Chen
Journal:  J Ind Microbiol Biotechnol       Date:  2014-03-27       Impact factor: 3.346

5.  Redefining the role of the quaternary shift in Bacillus stearothermophilus phosphofructokinase.

Authors:  Rockann Mosser; Manchi C M Reddy; John B Bruning; James C Sacchettini; Gregory D Reinhart
Journal:  Biochemistry       Date:  2013-07-31       Impact factor: 3.162

6.  Allosteric regulation in phosphofructokinase from the extreme thermophile Thermus thermophilus.

Authors:  Maria S McGresham; Michelle Lovingshimer; Gregory D Reinhart
Journal:  Biochemistry       Date:  2013-12-27       Impact factor: 3.162

7.  Evolution of allosteric citrate binding sites on 6-phosphofructo-1-kinase.

Authors:  Aleksandra Usenik; Matic Legiša
Journal:  PLoS One       Date:  2010-11-23       Impact factor: 3.240

8.  The pH dependence of the allosteric response of human liver pyruvate kinase to fructose-1,6-bisphosphate, ATP, and alanine.

Authors:  Aron W Fenton; Myra Hutchinson
Journal:  Arch Biochem Biophys       Date:  2009-01-20       Impact factor: 4.013

9.  Posttranslational modification of 6-phosphofructo-1-kinase as an important feature of cancer metabolism.

Authors:  Andreja Šmerc; Eva Sodja; Matic Legiša
Journal:  PLoS One       Date:  2011-05-04       Impact factor: 3.240

10.  Characterization of phosphofructokinase activity in Mycobacterium tuberculosis reveals that a functional glycolytic carbon flow is necessary to limit the accumulation of toxic metabolic intermediates under hypoxia.

Authors:  Wai Yee Phong; Wenwei Lin; Srinivasa P S Rao; Thomas Dick; Sylvie Alonso; Kevin Pethe
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.